Search research articles
Contact Us
Filters
Showing results (1-10 of 88) with videos related to
Page
of 9
Sort By:
Biomarkers in Medicine
|
August 25, 2011
Role of CSF biomarkers in the diagnosis of prodromal Alzheimer's disease
Lucilla Parnetti, Davide Chiasserini
Frontiers in Neurology
|
July 16, 2015
Preanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Issue of Diurnal Variation
Claudia Cicognola, Davide Chiasserini, Lucilla Parnetti
Biomarkers in Medicine
|
December 9, 2015
Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis
Lucilla Parnetti, Claudia Cicognola, Paolo Eusebi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 20, 2016
Glucocerebrosidase in Parkinson's disease: Insights into pathogenesis and prospects for treatment
Anthony H V Schapira, Davide Chiasserini, Tommaso Beccari, et al.
Biomolecules
|
January 26, 2024
Kidney Fibrosis and Oxidative Stress: From Molecular Pathways to New Pharmacological Opportunities
Francesco Patera, Leonardo Gatticchi, Barbara Cellini, et al.
Cancers
|
October 19, 2019
Proteomic Biomarkers for the Detection of Endometrial Cancer
Kelechi Njoku, Davide Chiasserini, Anthony D Whetton, et al.
Journal of Alzheimer'S Disease : JAD
|
May 14, 2010
Mitochondria and the link between neuroinflammation and neurodegeneration
Massimiliano Di Filippo, Davide Chiasserini, Alessandro Tozzi, et al.
Expert Review of Molecular Diagnostics
|
October 30, 2023
Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's disease
Lorenzo Gaetani, Davide Chiasserini, Federico Paolini Paoletti, et al.
Alzheimer'S Research & Therapy
|
September 30, 2020
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?
Giovanni Bellomo, Samuela Cataldi, Silvia Paciotti, et al.
Clinical Chemistry and Laboratory Medicine
|
September 1, 2023
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa<sup>®</sup> assays targeting distinct amyloid regions
Anna Lidia Wojdała, Giovanni Bellomo, Andrea Toja, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 88) with videos related to
Sort By:
Page
of 9
Biomarkers in Medicine
|
August 25, 2011
Role of CSF biomarkers in the diagnosis of prodromal Alzheimer's disease
Lucilla Parnetti, Davide Chiasserini
Frontiers in Neurology
|
July 16, 2015
Preanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Issue of Diurnal Variation
Claudia Cicognola, Davide Chiasserini, Lucilla Parnetti
Biomarkers in Medicine
|
December 9, 2015
Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis
Lucilla Parnetti, Claudia Cicognola, Paolo Eusebi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 20, 2016
Glucocerebrosidase in Parkinson's disease: Insights into pathogenesis and prospects for treatment
Anthony H V Schapira, Davide Chiasserini, Tommaso Beccari, et al.
Biomolecules
|
January 26, 2024
Kidney Fibrosis and Oxidative Stress: From Molecular Pathways to New Pharmacological Opportunities
Francesco Patera, Leonardo Gatticchi, Barbara Cellini, et al.
Cancers
|
October 19, 2019
Proteomic Biomarkers for the Detection of Endometrial Cancer
Kelechi Njoku, Davide Chiasserini, Anthony D Whetton, et al.
Journal of Alzheimer'S Disease : JAD
|
May 14, 2010
Mitochondria and the link between neuroinflammation and neurodegeneration
Massimiliano Di Filippo, Davide Chiasserini, Alessandro Tozzi, et al.
Expert Review of Molecular Diagnostics
|
October 30, 2023
Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's disease
Lorenzo Gaetani, Davide Chiasserini, Federico Paolini Paoletti, et al.
Alzheimer'S Research & Therapy
|
September 30, 2020
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?
Giovanni Bellomo, Samuela Cataldi, Silvia Paciotti, et al.
Clinical Chemistry and Laboratory Medicine
|
September 1, 2023
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa<sup>®</sup> assays targeting distinct amyloid regions
Anna Lidia Wojdała, Giovanni Bellomo, Andrea Toja, et al.
Page
of 9